ICCM (IceCure Medical, Ltd.) נכסים נקיים של החברה

The IceCure Medical Ltd (ICCM) business model relies on the implementation of ProSense systems for the destruction of neoplasms, which is reflected in the market value trend on the GURU.Markets platform, where the current indicator is 0.01. By supplying tissue freezing equipment, IceCure Medical Ltd (ICCM) generates steady demand for disposable probes. Simultaneously, the company is deploying automated cryoablation complexes featuring software-controlled temperature regimes and digital tracking of therapy protocols.

To minimize volatility risks, it is crucial for investors to filter out speculative noise by assessing the real value of the company's net assets. This metric captures the actual equity after trading, and the balance sheet capital history of IceCure Medical Ltd (ICCM) allows for monitoring the financing efficiency of the ProSense technology expansion and the costs associated with obtaining FDA approvals to capture the therapeutic market.